Literature DB >> 23299601

How to decide whether a clinical practice guideline is trustworthy.

David F Ransohoff1, Michael Pignone, Harold C Sox.   

Abstract

Mesh：

Year:  2013        PMID： 23299601     DOI： 10.1001/jama.2012.156703

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  25 in total

Review 1.  A critical review of recent clinical practice guidelines on the diagnosis and treatment of non-neurogenic male lower urinary tract symptoms.

Authors:  Michael Erlano Chua; Jonathan Mendoza; Manuel See; Ednalyn Esmena; Dean Aguila; Jan Michael Silangcruz; Buenaventura Jose Reyes; Saturnino Luna; Marcelino Morales
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  The new cholesterol and blood pressure guidelines: perspective on the path forward.

Authors:  Harlan M Krumholz
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

3.  A critical review of recent clinical practice guidelines for pediatric urinary tract infection.

Authors:  Michael Chua; Jessica Ming; Shang-Jen Chang; Joana Dos Santos; Niraj Mistry; Jan Michael Silangcruz; Mark Bayley; Martin A Koyle
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

4.  Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE): 2014 update.

Authors:  Sheldon W Tobe; James A Stone; Kimberly M Walker; Todd Anderson; Onil Bhattacharyya; Alice Y Y Cheng; Jean Gregoire; Gord Gubitz; Mary L'Abbé; David C W Lau; Lawrence A Leiter; Paul Oh; Raj Padwal; Luc Poirier; Peter Selby; Mark Tremblay; Richard A Ward; Diane Hua; Peter P Liu
Journal:  CMAJ       Date:  2014-10-20       Impact factor: 8.262

5.  Methodological quality of national guidelines for pediatric inpatient conditions.

Authors:  Gabrielle Hester; Katherine Nelson; Sanjay Mahant; Emily Eresuma; Ron Keren; Rajendu Srivastava
Journal:  J Hosp Med       Date:  2014-03-28       Impact factor: 2.960

6.  Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.

Authors:  Guillaume Hébert; Florence Netzer; Sylvain Landry Kouakou; François Lemare; Etienne Minvielle
Journal:  Int J Clin Pharm       Date:  2018-02-14

Review 7.  Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).

Authors:  Nicola Dalbeth; Thomas Bardin; Michael Doherty; Frédéric Lioté; Pascal Richette; Kenneth G Saag; Alexander K So; Lisa K Stamp; Hyon K Choi; Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2017-08-10       Impact factor: 20.543

8.  Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.

Authors:  Kana Yamamoto; Anju Murayama; Akihiko Ozaki; Hiroaki Saito; Toyoaki Sawano; Tetsuya Tanimoto
Journal:  Int Urogynecol J       Date:  2020-11-05       Impact factor: 2.894

9.  Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Deep Brain Stimulations for Obsessive-Compulsive Disorder: Update of the 2014 Guidelines.

Authors:  Michael D Staudt; Nader Pouratian; Jonathan P Miller; Clement Hamani; Nataly Raviv; Guy M McKhann; Jorge A Gonzalez-Martinez; Julie G Pilitsis
Journal:  Neurosurgery       Date:  2021-03-15       Impact factor: 4.654

10.  Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines.

Authors:  Jarryd Horn; Jake Xavier Checketts; Omar Jawhar; Matt Vassar
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-03-01       Impact factor: 6.223
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.